FP7Индивидуална стипендия2009–2011

CHACT_RHAZ · Metal catalysed C–H bond activation strategies for chemical synthesis & cancer biology

7РП — „Хора“ (Действия „Мария Кюри“)

Период
2009-04-06 → 2011-04-05
Финансиране от ЕС
182 485 €
Участници
1
Схема
MC-IIF

Линиите свързват координатора с партньорите.

Накратко на български

Металите се използват като катализатори за промяна на химични връзки, което позволява превръщането на лекарства като ибупрофен в нови съединения. Този метод прави химичния синтез по-екологичен и улеснява създаването на сложни молекули за фармацията.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Metal catalysed C-H bond activation strategies for chemical synthesis & cancer biology

Despite the changing face of organic chemistry one aspect remains persistent: the ability to make molecules to order is something that, even now, is still unique to the synthetic chemist. What is changing in synthesis is the way that we go about achieving our goal. More than ever it is essential to consider the impact of atom economy, catalysis and stereocontrol as chemical synthesis strives to become 'green'. The area of metal catalysed C-H bond activation is a rapidly developing field in chemical synthesis as it addresses many of the aforementioned deficiencies of conventional metal chemistry. However, despite its importance the field is still in its infancy and if it is going to become a central paradigm for chemical synthesis then a great deal of investigation needs to be invested in its development. Over the past decade, there has been much attention on C-H arylation of arenes since the product biaryl unit is frequently found in many important biologically interesting compounds, pharmaceutical reagents and functional polymers. However, these processes have been limited to the functionalisation of a C-H bond adjacent to a directing group (ortho C-H functionalisation). Clearly, full potential can only be realised when other positions of arene ring can be arylated. The researcher has successfully developed a novel site-selective C-H bond functionalisation process employing inexpensive copper catalysts. The use of hypervalent iodine compounds allows arylation to occur at the meta C-H bond relative to a carbonyl directing group. This exquisite regiocontrol allows access to a variety of interesting compounds that are not easy to obtain via traditional chemistry. In particular, the methodology facilitates facile conversion of drug molecules, such as ibuprofen, into biaryl analogues for further biological studies. The researcher also discovered a condition for metal-free C-H arylation. This finding offers exciting potentials for further developments since it avoids the use of metal catalyst, which in many cases is difficult to separate from products and affects the quality of the desired materials.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Chemical synthesis relies on the presence of functional groups to control the formation of new bonds. The area of catalytic C–H bond functionalisation offers a pioneering opportunity to develop highly efficient, ‘green’ and new chemical transformation that will be pivotal in the future development of chemical synthesis. While we are not suggesting that this approach will replace the conventional tactics of molecule assembly it does offer the synthetic chemist the chance to explore completely unknown strategies. More specifically, it allows us to put the standard rulebook of disconnections to one side and invent a new set of reactions that allow us to break down a molecule without needing to locate a functional group in the synthons. Breaking a C–C, C–N or C–O bond back to a number of C–H bonds represents the pinnacle of modern synthetic chemistry. To achieve this would allow metal catalysed C–H bond functionalisation strategies to offer a conceptually new approach to synthesis that will compliment conventional synthesis and enable us to move a step closer to being able to assemble any desired molecule. As part of this proposal we aim to develop a metal catalyzed C–H bond functionalization strategy that will enable the rapid and flexible synthesis of the intriguing tubulin destabilizing agent, rhazinilam. Furthermore, we will also investigate a totally unprecedented natural product re-arrangement strategy that enables the facile conversion of the rhazinilam framework into the aspidospermidine framework. This rearrangement blueprint, that the Host group name ‘retro-biosynthesis’ as it goes against the proposed classical biosynthetetic pathway, provides immediate access to a family of compounds (the vinca alkaloids) that have potent biological activities in cancer medicine.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз